Assertion list
trial (primary) → ReceivesAction

Results from Ascent++: 428
trialReceivesAction completed 0.70
trialReceivesAction registered 0.70
trialReceivesAction conducted 0.69
trialReceivesAction conducted in accordance 0.68
trialReceivesAction conducted in the united states 0.66
trialReceivesAction concluded 0.66
trialReceivesAction randomized 0.65
trialReceivesAction excluded 0.65
trialReceivesAction designed 0.65
trialReceivesAction included in the analysis 0.64
trialReceivesAction included in the meta-analysis 0.64
trialReceivesAction held in the state 0.64
trialReceivesAction run 0.63
trialReceivesAction registered at clinicaltrials.gov 0.63
trialReceivesAction designed to assess tolerability 0.61
trialReceivesAction conducted in australia 0.61
trialReceivesAction repeated 0.61
trialReceivesAction recorded 0.61
trialReceivesAction presented in random order 0.61
trialReceivesAction analyzed 0.60
trialReceivesAction conducted in compliance 0.60
trialReceivesAction selected 0.59
trialReceivesAction stopped 0.59
trialReceivesAction initiated 0.59
trialReceivesAction heard by judge 0.58
trialReceivesAction conducted in europe 0.58
trialReceivesAction combined 0.57
trialReceivesAction concerned 0.57
trialReceivesAction funded by grant 0.57
trialReceivesAction carried out in accordance 0.57
trialReceivesAction conducted in the uk 0.57
trialReceivesAction conducted in china 0.56
trialReceivesAction approved by institutional revie… 0.56
trialReceivesAction shown 0.56
trialReceivesAction conducted in india 0.56
trialReceivesAction conducted in italy 0.56
trialReceivesAction listed in table 0.56
trialReceivesAction assessed for quality 0.56
trialReceivesAction published in english 0.55
trialReceivesAction scheduled for november 0.55
trialReceivesAction approved by the ethics committee 0.55
trialReceivesAction pooled 0.55
trialReceivesAction implemented 0.55
trialReceivesAction funded by industry 0.55
trialReceivesAction conducted in asia 0.55
trialReceivesAction held without jury 0.55
trialReceivesAction of high quality 0.55
trialReceivesAction conducted in 2013 0.55
trialReceivesAction funded by pfizer 0.54
trialReceivesAction suspended 0.54
trialReceivesAction conducted in germany 0.54
trialReceivesAction eligible for inclusion 0.54
trialReceivesAction postponed 0.54
trialReceivesAction sponsored by pharmaceutical com… 0.53
trialReceivesAction funded by pharmaceutical compan… 0.53
trialReceivesAction adjourned 0.53
trialReceivesAction conducted in canada 0.53
trialReceivesAction cancelled 0.52
trialReceivesAction removed 0.52
trialReceivesAction due to start 0.52
trialReceivesAction ordered 0.52
trialReceivesAction delayed 0.52
trialReceivesAction held behind closed doors 0.52
trialReceivesAction held in public 0.52
trialReceivesAction presented in randomized order 0.52
trialReceivesAction resolved 0.52
trialReceivesAction conducted in patient 0.52
trialReceivesAction reported 0.51
trialReceivesAction replicated 0.51
trialReceivesAction heard 0.51
trialReceivesAction conducted in north america 0.51
trialReceivesAction heard by jury 0.51
trialReceivesAction put on hold 0.51
trialReceivesAction completed in december 0.51
trialReceivesAction held in open court 0.51
trialReceivesAction regarded 0.51
trialReceivesAction carried out in the usa 0.51
trialReceivesAction continued 0.50
trialReceivesAction discarded 0.50
trialReceivesAction extended 0.50
trialReceivesAction accepted 0.50
trialReceivesAction arranged 0.50
trialReceivesAction included in the cochrane review 0.50
trialReceivesAction laid out in randomized complete… 0.50
trialReceivesAction timed 0.50
trialReceivesAction published in 2015 0.50
trialReceivesAction sponsored by company 0.50
trialReceivesAction limited 0.50
trialReceivesAction biased 0.49
trialReceivesAction inspected 0.49
trialReceivesAction judged to be at low risk of bias 0.49
trialReceivesAction reported in accordance 0.49
trialReceivesAction carried out in europe 0.49
trialReceivesAction rescheduled 0.49
trialReceivesAction planned 0.49
trialReceivesAction held 0.49
trialReceivesAction conducted in japan 0.49
trialReceivesAction set 0.49
trialReceivesAction published in jama 0.49
trialReceivesAction conducted in adult 0.49
trialReceivesAction presented in pseudorandom order 0.49
trialReceivesAction regulated 0.49
trialReceivesAction sown 0.49
trialReceivesAction published in journal 0.49
trialReceivesAction conducted in child 0.48
trialReceivesAction held in miami 0.48
trialReceivesAction televised 0.48
trialReceivesAction published in 2004 0.47
trialReceivesAction closed 0.47
trialReceivesAction designed to evaluate safety 0.47
trialReceivesAction terminated 0.47
trialReceivesAction filmed 0.47
trialReceivesAction flawed 0.47
trialReceivesAction held in the united states 0.47
trialReceivesAction included in systematic review 0.47
trialReceivesAction conducted in partnership 0.47
trialReceivesAction abandoned 0.46
trialReceivesAction completed in march 0.46
trialReceivesAction conducted in country 0.46
trialReceivesAction identified 0.46
trialReceivesAction conducted in collaboration 0.46
trialReceivesAction tried 0.46
trialReceivesAction collected 0.46
trialReceivesAction conducted in hospital 0.46
trialReceivesAction conducted in high-income countr… 0.46
trialReceivesAction rejected 0.46
trialReceivesAction conducted in argentina 0.45
trialReceivesAction published in the bmj 0.45
trialReceivesAction closed to the public 0.45
trialReceivesAction designed to assess efficacy 0.45
trialReceivesAction set for june 0.45
trialReceivesAction of low quality 0.45
trialReceivesAction conducted on treatment 0.45
trialReceivesAction conducted on human 0.45
trialReceivesAction sponsored by the national cance… 0.45
trialReceivesAction related 0.45
trialReceivesAction sponsored by nih 0.45
trialReceivesAction targeted 0.45
trialReceivesAction conducted on people 0.45
trialReceivesAction averaged 0.45
trialReceivesAction offered by the business 0.44
trialReceivesAction scheduled for september 0.44
trialReceivesAction held in april 0.44
trialReceivesAction designed to evaluate pharmacoki… 0.44
trialReceivesAction scheduled 0.44
trialReceivesAction funded by the national institut… 0.44
trialReceivesAction held in march 0.44
trialReceivesAction monitored 0.44
trialReceivesAction funded by the national institute 0.43
trialReceivesAction set for february 0.43
trialReceivesAction established 0.43
trialReceivesAction had 0.43
trialReceivesAction organized 0.43
trialReceivesAction rigged 0.43
trialReceivesAction won 0.42
trialReceivesAction conducted in france 0.42
trialReceivesAction conducted at two prestigious ca… 0.42
trialReceivesAction completed by particular tribunal 0.42
trialReceivesAction registered with the chinese cli… 0.42
trialReceivesAction scheduled for january 0.42
trialReceivesAction allowed 0.42
trialReceivesAction conducted in addition 0.42
trialReceivesAction scheduled for may 0.42
trialReceivesAction expected 0.42
trialReceivesAction likely to published 0.42
trialReceivesAction resumed 0.42
trialReceivesAction scheduled for october 0.42
trialReceivesAction about to begin 0.41
trialReceivesAction overcome 0.41
trialReceivesAction funded by the medical research … 0.41
trialReceivesAction held in nuremberg 0.41
trialReceivesAction held in secret 0.41
trialReceivesAction launched 0.41
trialReceivesAction recommended 0.41
trialReceivesAction conducted in south africa 0.41
trialReceivesAction followed 0.41
trialReceivesAction understood 0.41
trialReceivesAction warranted 0.41
trialReceivesAction carried out in germany 0.41
trialReceivesAction scheduled for july 0.41
trialReceivesAction separated 0.41
trialReceivesAction reported as abstract 0.40
trialReceivesAction broadcast 0.40
trialReceivesAction submitted to the fda 0.40
trialReceivesAction expanded 0.40
trialReceivesAction created 0.39
trialReceivesAction judged to be at high risk of bi… 0.39
trialReceivesAction examined 0.39
trialReceivesAction held in january 0.39
trialReceivesAction scheduled to begin in march 0.39
trialReceivesAction developed 0.39
trialReceivesAction funded by cancer research uk 0.39
trialReceivesAction funded by merck 0.39
trialReceivesAction due to finish 0.38
trialReceivesAction scheduled for december 0.38
trialReceivesAction changed 0.38
trialReceivesAction conducted outside the u.s. 0.38
trialReceivesAction held in court 0.38
trialReceivesAction adjourned until may 0.38
trialReceivesAction announced 0.38
trialReceivesAction led by researcher 0.38
trialReceivesAction likely to be valid 0.38
trialReceivesAction published in the lancet 0.38
trialReceivesAction pushed 0.38
trialReceivesAction scheduled to begin on april 0.38
trialReceivesAction scheduled to start in february 0.38
trialReceivesAction adjourned until november 0.38
trialReceivesAction conducted in 2014 0.38
trialReceivesAction due to end 0.38
trialReceivesAction held in february 0.38
trialReceivesAction held in july 0.38
trialReceivesAction re 0.38
trialReceivesAction carried out in canada 0.37
trialReceivesAction conducted in the netherlands 0.37
trialReceivesAction funded by blood institute 0.37
trialReceivesAction held in august 0.37
trialReceivesAction postponed to march 0.37
trialReceivesAction published in 2016 0.37
trialReceivesAction aborted 0.37
trialReceivesAction conducted in 2017 0.37
trialReceivesAction funded by astrazeneca 0.37
trialReceivesAction funded by the national heart 0.37
trialReceivesAction held before the international m… 0.37
trialReceivesAction convicted 0.37
trialReceivesAction listed on clinicaltrials.gov 0.36
trialReceivesAction approved by the fda 0.36
trialReceivesAction held before u.s. military courts 0.36
trialReceivesAction held in october 0.36
trialReceivesAction published in 2012 0.36
trialReceivesAction set for august 0.36
trialReceivesAction added 0.36
trialReceivesAction conducted in new zealand 0.36
trialReceivesAction conducted in south korea 0.36
trialReceivesAction conducted in spain 0.36
trialReceivesAction divided into three phases 0.36
trialReceivesAction funded by the nih 0.36
trialReceivesAction held in federal court 0.36
trialReceivesAction held on saturday 0.36
trialReceivesAction set for monday 0.36
trialReceivesAction allowed in said court 0.36
trialReceivesAction conducted in belgium 0.36
trialReceivesAction conducted in uganda 0.36
trialReceivesAction held in camera 0.36
trialReceivesAction prepared 0.36
trialReceivesAction proposed 0.36
trialReceivesAction registered with isrctn 0.36
trialReceivesAction restricted to patient 0.36
trialReceivesAction sponsored by the university of … 0.36
trialReceivesAction waived 0.36
trialReceivesAction watched 0.36
trialReceivesAction written by franz kafka 0.36
trialReceivesAction conducted in finland 0.35
trialReceivesAction conducted in mexico 0.35
trialReceivesAction expedited 0.35
trialReceivesAction funded by the wellcome trust 0.35
trialReceivesAction held in new york city 0.35
trialReceivesAction passed 0.35
trialReceivesAction protected 0.35
trialReceivesAction published in 2005 0.35
trialReceivesAction published in 2010 0.35
trialReceivesAction published to date 0.35
trialReceivesAction sponsored by novartis 0.35
trialReceivesAction sponsored by the national heart 0.35
trialReceivesAction found unto glory 0.35
trialReceivesAction based on evidence 0.34
trialReceivesAction based on fact 0.34
trialReceivesAction conducted in kenya 0.34
trialReceivesAction conducted in melbourne 0.34
trialReceivesAction conducted in parallel 0.34
trialReceivesAction designed to assess effectiveness 0.34
trialReceivesAction eliminated 0.34
trialReceivesAction handled 0.34
trialReceivesAction held at the old bailey 0.34
trialReceivesAction published in 2011 0.34
trialReceivesAction restarted 0.34
trialReceivesAction scored 0.34
trialReceivesAction sponsored by blood 0.34
trialReceivesAction stopped for efficacy 0.34
trialReceivesAction omitted 0.34
trialReceivesAction used by god 0.34
trialReceivesAction bifurcated 0.34
trialReceivesAction broadcast on television 0.34
trialReceivesAction conducted in africa 0.34
trialReceivesAction conducted in brazil 0.34
trialReceivesAction conducted in sydney 0.34
trialReceivesAction funded by the charity 0.34
trialReceivesAction held at the start of the year 0.34
trialReceivesAction likely to result 0.34
trialReceivesAction performed on larger groups 0.34
trialReceivesAction presided by judge 0.34
trialReceivesAction set for next month 0.34
trialReceivesAction sponsored by eli lilly 0.34
trialReceivesAction stayed 0.34
trialReceivesAction structured 0.34
trialReceivesAction never published 0.33
trialReceivesAction adapted 0.33
trialReceivesAction adjourned to another date 0.33
trialReceivesAction completed in january 0.33
trialReceivesAction completed in june 0.33
trialReceivesAction conducted by a team of individu… 0.33
trialReceivesAction conducted in english 0.33
trialReceivesAction conducted in south america 0.33
trialReceivesAction conducted in sweden 0.33
trialReceivesAction conducted in thailand 0.33
trialReceivesAction funded by the department 0.33
trialReceivesAction given with paclitaxel 0.33
trialReceivesAction likely to begin 0.33
trialReceivesAction published in march 0.33
trialReceivesAction sponsored by the national center 0.33
trialReceivesAction sponsored by the nci 0.33
trialReceivesAction avoided 0.33
trialReceivesAction criticized 0.33
trialReceivesAction adjourned for week 0.32
trialReceivesAction adjourned until february 0.32
trialReceivesAction administered 0.32
trialReceivesAction approved by health canada 0.32
trialReceivesAction completed in february 0.32
trialReceivesAction completed under nct02722408 0.32
trialReceivesAction conducted at site 0.32
trialReceivesAction conducted by a research team 0.32
trialReceivesAction conducted in absentia 0.32
trialReceivesAction conducted in costa rica 0.32
trialReceivesAction conducted in switzerland 0.32
trialReceivesAction demanded 0.32
trialReceivesAction designed to evaluate following … 0.32
trialReceivesAction designed to evaluate immunogeni… 0.32
trialReceivesAction dismissed 0.32
trialReceivesAction divided into two groups 0.32
trialReceivesAction explored 0.32
trialReceivesAction funded by nonprofit or nonfeder… 0.32
trialReceivesAction funded by the national institut… 0.32
trialReceivesAction held in september 0.32
trialReceivesAction known in each state 0.32
trialReceivesAction led by the world health organiz… 0.32
trialReceivesAction overseen by a steering committee 0.32
trialReceivesAction published in 2008 0.32
trialReceivesAction run with school 0.32
trialReceivesAction scheduled for next year 0.32
trialReceivesAction discontinued 0.32
trialReceivesAction appointed to be had before the … 0.32
trialReceivesAction approved by local ethics commit… 0.32
trialReceivesAction completed on time 0.32
trialReceivesAction conducted at 5 locations 0.32
trialReceivesAction conducted at the university of … 0.32
trialReceivesAction conducted at the university of … 0.32
trialReceivesAction conducted in 1970 0.32
trialReceivesAction conducted in peru 0.32
trialReceivesAction confirmed 0.32
trialReceivesAction constructed 0.32
trialReceivesAction designed in consultation 0.32
trialReceivesAction designed to answer the question 0.32
trialReceivesAction due to last 0.32
trialReceivesAction established in cooperation 0.32
trialReceivesAction fought 0.32
trialReceivesAction funded by melinda gates foundat… 0.32
trialReceivesAction funded by niaid 0.32
trialReceivesAction funded by two uk funding agenci… 0.32
trialReceivesAction guaranteed 0.32
trialReceivesAction had on complaint 0.32
trialReceivesAction held at special court 0.32
trialReceivesAction held in closed session 0.32
trialReceivesAction held in scotland 0.32
trialReceivesAction held in the netherlands 0.32
trialReceivesAction joined with date 0.32
trialReceivesAction postponed to september 0.32
trialReceivesAction proceeded 0.32
trialReceivesAction published in 1996 0.32
trialReceivesAction published in 2007 0.32
trialReceivesAction published in abstract form 0.32
trialReceivesAction published in peer-reviewed jour… 0.32
trialReceivesAction published since 2002 0.32
trialReceivesAction registered in the dutch trial r… 0.32
trialReceivesAction set within 6 judicial workingda… 0.32
trialReceivesAction shown in figure 0.32
trialReceivesAction split into two parts 0.32
trialReceivesAction sponsored by other federal agen… 0.32
trialReceivesAction staged 0.32
trialReceivesAction lost 0.31
trialReceivesAction announced in january 0.31
trialReceivesAction completed in november 0.31
trialReceivesAction concluded in two years 0.31
trialReceivesAction conducted by the national cance… 0.31
trialReceivesAction conducted in august 0.31
trialReceivesAction conducted in israel 0.31
trialReceivesAction conducted in london 0.31
trialReceivesAction designed to evaluate the propor… 0.31
trialReceivesAction funded by the bill 0.31
trialReceivesAction held in a lucknow court 0.31
trialReceivesAction held in courtroom 0.31
trialReceivesAction intermixed 0.31
trialReceivesAction judged on speed 0.31
trialReceivesAction presented in total 0.31
trialReceivesAction published in the nejm 0.31
trialReceivesAction scheduled to begin may 0.31
trialReceivesAction sponsored by academic instituti… 0.31
trialReceivesAction sponsored by institute 0.31
trialReceivesAction sponsored by roche 0.31
trialReceivesAction ignored 0.31
trialReceivesAction compared 0.30
trialReceivesAction found unto honour 0.30
trialReceivesAction conducted to date 0.29
trialReceivesAction stopped for futility 0.29
trialReceivesAction difficult to conduct 0.28
trialReceivesAction delayed by procedural matters 0.27
trialReceivesAction interrupted 0.26
trialReceivesAction conducted in way 0.26
trialReceivesAction published in chinese journals 0.26
trialReceivesAction politicised 0.25
trialReceivesAction demolished by investigator 0.24
trialReceivesAction abolished 0.24
trialReceivesAction charged with murder 0.24
trialReceivesAction conducted in much informal fash… 0.24
trialReceivesAction considered harmful 0.24
trialReceivesAction likely to succeed 0.24
trialReceivesAction prejudiced 0.24
trialReceivesAction tainted 0.24
trialReceivesAction condemned by international comm… 0.23
trialReceivesAction marred by delay 0.23
trialReceivesAction stalled 0.23
trialReceivesAction accused of crime 0.22
trialReceivesAction published in non-chinese journa… 0.22
trialReceivesAction instituted 0.22
trialReceivesAction published in the british medica… 0.21
trialReceivesAction delayed for year 0.21
trialReceivesAction fixed 0.18
trialReceivesAction dropped 0.16
trialReceivesAction requested 0.15
trialReceivesAction authorised 0.15